Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SENP2 | Q9HC62 | 17/20 | 0.57 |
| ▸ | SENP1 | Q9P0U3 | 17/20 | 0.57 |
| ▸ | SENP5 | Q96HI0 | 16/20 | 0.57 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4603693 | 0.94 | SENP2 (0.59) | SENP2SENP1SENP5MRGPRX4TP53 | |
| SCHEMBL4604537 | 0.90 | SENP2 (0.60) | SENP2SENP1SENP5USP2 | |
| SCHEMBL4605734 | 0.88 | SENP2 (0.53) | SENP2SENP1SENP5USP2 | |
| SCHEMBL4634974 | 0.86 | SENP5 (0.53) | SENP2SENP1SENP5MRGPRX4USP2 | |
| SCHEMBL4604976 | 0.82 | SENP5 (0.63) | SENP2SENP1SENP5USP2 | |
| SCHEMBL4604177 | 0.81 | SENP2 (0.58) | SENP2SENP1SENP5USP2 | |
| SCHEMBL4604073 | 0.81 | SENP2 (0.58) | SENP2SENP1SENP5USP2RXFP1 | |
| SCHEMBL4634951 | 0.81 | KDM4E (0.67) | SENP2SENP1SENP5USP2 | |
| SCHEMBL4604237 | 0.80 | SENP2 (0.48) | SENP2SENP1SENP5USP2 | |
| SCHEMBL4603993 | 0.80 | SENP5 (0.47) | SENP2SENP1SENP5USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1685122-B1 | BENZOFURANS AND BENZOTHIOPHENES | MERCK PATENT GMBH (DE) | 2008-07-09 | — | — | EP | disclosed |
| US-7371774-B2 | Benzofurans and benzothiophenes | MERCK PATENT GMBH (DE) | 2008-05-13 | — | — | US | disclosed |
| US-20070066680-A1 | Benzofurans and benzothiophenes | MERCK PATENT GMBH (DE) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066680-A1 | Benzofurans and benzothiophenes | INSR, GPR119, IGF1R | SENP2 4103/4885SENP1 3205/4885SENP5 3478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.